Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives

References

• Parodi A, Molinaro R, Sushnitha M, et al. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery. Biomaterials. 2017 Dec;147:155–168. PubMed PMID: 28946131.
   PubMed Web of Science ®Google Scholar
• Lindenbach BD, Rice CM. The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol. 2013 Oct;11(10):688–700. PubMed PMID: 24018384; PubMed Central PMCID: PMCPMC3897199.
   PubMed Web of Science ®Google Scholar
• Messaoudi I, Amarasinghe GK, Basler CF. Filovirus pathogenesis and immune evasion: insights from ebola virus and marburg virus. Nat Rev Microbiol. 2015 Nov;13(11):663–676. PubMed PMID: 26439085; PubMed Central PMCID: PMCPMC5201123.
   PubMed Web of Science ®Google Scholar
• Rossman JS, Leser GP, Lamb RA. Filamentous influenza virus enters cells via macropinocytosis. J Virol. 2012 Oct;86(20):10950–10960. PubMed PMID: 22875971; PubMed Central PMCID: PMCPMC3457176.
   PubMed Web of Science ®Google Scholar
• Sycuro LK, Pincus Z, Gutierrez KD, et al. Peptidoglycan crosslinking relaxation promotes helicobacter pylori’s helical shape and stomach colonization. Cell. 2010 May 28;141(5):822–833. PubMed PMID: 20510929; PubMed Central PMCID: PMCPMC2920535.
   PubMed Web of Science ®Google Scholar
• Huang X, Teng X, Chen D, et al. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials. 2010 Jan;31(3):438–448. PubMed PMID: 19800115. .
   PubMed Web of Science ®Google Scholar
• Champion JA, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res. 2009 Jan;26(1):244–249. PubMed PMID: 18548338; PubMed Central PMCID: PMCPMC2810499.
   PubMed Web of Science ®Google Scholar
• Caldorera-Moore M, Guimard N, Shi L, et al. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv. 2010 Apr;7(4):479–495. PubMed PMID: 20331355; PubMed Central PMCID: PMCPMC2845970.
   PubMed Web of Science ®Google Scholar
• Shi X, von dem Bussche A, Hurt RH, et al. Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat Nanotechnol. 2011 Sep 18;6(11):714–719. PubMed PMID: 21926979; PubMed Central PMCID: PMCPMC3215144.
   PubMed Web of Science ®Google Scholar
• Li Y, Yue T, Yang K, et al. Molecular modeling of the relationship between nanoparticle shape anisotropy and endocytosis kinetics. Biomaterials. 2012 Jun;33(19):4965–4973. PubMed PMID: 22483010.
   PubMed Web of Science ®Google Scholar
• Li X, Tsibouklis J, Weng T, et al. Nano carriers for drug transport across the blood-brain barrier. J Drug Target. 2017 Jan;25(1):17–28. PubMed PMID: 27126681.
   PubMed Web of Science ®Google Scholar
• Liu X, Wu F, Tian Y, et al. Size dependent cellular uptake of rod-like bionanoparticles with different aspect ratios. Sci Rep. 2016 Apr 15;6:24567. PubMed PMID: 27080246; PubMed Central PMCID: PMCPMC4832221.
   PubMed Web of Science ®Google Scholar
• Jurney P, Agarwal R, Singh V, et al. Unique size and shape-dependent uptake behaviors of non-spherical nanoparticles by endothelial cells due to a shearing flow. J Control Release. 2017 Jan 10;245:170–176. PubMed PMID: 27916535.
   PubMed Web of Science ®Google Scholar
• Hinde E, Thammasiraphop K, Duong HT, et al. Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release. Nat Nanotechnol. 2017 Jan;12(1):81–89. PubMed PMID: 27618255. .
   PubMed Web of Science ®Google Scholar
• Seidi F, Jenjob R, Crespy D. Designing smart polymer conjugates for controlled release of payloads. Chem Rev. 2018 Mar 13;118:3965–4036.
   PubMed Web of Science ®Google Scholar
• Mittal R, Patel AP, Jhaveri VM, et al. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opin Drug Deliv. 2018 Mar;15(3):301–318. PubMed PMID: 29272976.
   PubMed Web of Science ®Google Scholar
• Hua XW, Bao YW, Wu FG. Fluorescent carbon quantum dots with intrinsic nucleolus-targeting capability for nucleolus imaging and enhanced cytosolic and nuclear drug delivery. ACS Appl Mater Interfaces. 2018 Apr 4;10(13):10664–10677. PubMed PMID: 29508612.
   PubMed Web of Science ®Google Scholar
• Cabrera D, Coene A, Leliaert J, et al. Dynamical magnetic response of iron oxide nanoparticles inside live cells. ACS Nano. 2018 Mar 27;12(3):2741–2752. PubMed PMID: 29508990.
   PubMed Web of Science ®Google Scholar
• Ragelle H, Danhier F, Preat V, et al. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures. Expert Opin Drug Deliv. 2017 Jul;14(7):851–864. PubMed PMID: 27730820.
   PubMed Web of Science ®Google Scholar
• Meng F, Han N, Yeo Y. Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy. Expert Opin Drug Deliv. 2017 Mar;14(3):427–446. PubMed PMID: 27476442; PubMed Central PMCID: PMCPMC5385259.
   PubMed Web of Science ®Google Scholar
• Li BL, Setyawati MI, Chen L, et al. Directing assembly and disassembly of 2D MoS2 nanosheets with DNA for drug delivery. ACS Appl Mater Interfaces. 2017 May 10;9(18):15286–15296. PubMed PMID: 28452468.
   PubMed Web of Science ®Google Scholar
• Mokhtarzadeh A, Alibakhshi A, Hashemi M, et al. Biodegradable nano-polymers as delivery vehicles for therapeutic small non-coding ribonucleic acids. J Control Release. 2017 Jan 10;245:116–126. PubMed PMID: 27884808.
   PubMed Web of Science ®Google Scholar
• Wani A, Savithra GHL, Abyad A, et al. Surface PEGylation of Mesoporous Silica Nanorods (MSNR): effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells. Sci Rep. 2017 May 23;7(1):2274. PubMed PMID: 28536462; PubMed Central PMCID: PMCPMC5442097.
   PubMedGoogle Scholar
• Yamamoto E, Kuroda K. Colloidal mesoporous silica nanoparticles. Bull Chem Soc Jpn. 2016;89(5):501–539.
   Web of Science ®Google Scholar
• Wang Y, Zhao Q, Han N, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015 Feb;11(2):313–327. PubMed PMID: 25461284.
   PubMed Web of Science ®Google Scholar
• Chen X, Cheng X, Soeriyadi AH, et al. Stimuli-responsive functionalized mesoporous silica nanoparticles for drug release in response to various biological stimuli. Biomater Sci. 2014;2(1):121–130.
   Web of Science ®Google Scholar
• Chen X, Soeriyadi AH, Lu X, et al. Dual bioresponsive mesoporous silica nanocarrier as an “AND” logic gate for targeted drug delivery cancer cells. Adv Funct Mater. 2014;24(44):6999–7006.
   Web of Science ®Google Scholar
• Chen X, Liu Z, Parker SG, et al. Light-induced hydrogel based on tumor-targeting mesoporous silica nanoparticles as a theranostic platform for sustained cancer treatment. ACS Appl Mater Interfaces. 2016 Jun 29;8(25):15857–15863. PubMed PMID: 27265514.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen X, Zhang X, et al. Carbon-quantum-dots-loaded mesoporous silica nanocarriers with pH-switchable zwitterionic surface and enzyme-responsive pore-cap for targeted imaging and drug delivery to tumor. Adv Healthc Mater. 2016 Jun;5(12):1401–1407. PubMed PMID: 26987989.
   PubMed Web of Science ®Google Scholar
• Bobo D, Robinson KJ, Islam J, et al. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res. 2016 Oct;33(10):2373–2387. PubMed PMID: 27299311.
   PubMed Web of Science ®Google Scholar
• Vallet-Regi M, Colilla M, Izquierdo-Barba I, et al. Mesoporous silica nanoparticles for drug delivery: current insights. Molecules. 2017 Dec 25;23(1). PubMed PMID: 29295564.
   PubMed Web of Science ®Google Scholar
• Hao N, Li L, Tang F. Shape matters when engineering mesoporous silica-based nanomedicines. Biomater Sci. 2016 Apr;4(4):575–591. PubMed PMID: 26818852.
   PubMed Web of Science ®Google Scholar
• Hao N, Li L, Tang F. Roles of particle size, shape and surface chemistry of mesoporous silica nanomaterials on biological systems. Int Mater Rev. 2016;62(2):57–77.
   Web of Science ®Google Scholar
• Yi Z, Dumee LF, Garvey CJ, et al. A new insight into growth mechanism and kinetics of mesoporous silica nanoparticles by in situ small angle X-ray scattering. Langmuir. 2015 Aug 4;31(30):8478–8487. PubMed PMID: 26158700.
   PubMed Web of Science ®Google Scholar
• Blin JL, Imperor-Clerc M. Mechanism of self-assembly in the synthesis of silica mesoporous materials: in situ studies by X-ray and neutron scattering. Chem Soc Rev. 2013 May 7;42(9):4071–4082. PubMed PMID: 23258529.
   PubMed Web of Science ®Google Scholar
• Alothman Z. A review: fundamental aspects of silicate mesoporous materials. Materials. 2012;5(12):2874–2902.
   Web of Science ®Google Scholar
• Danks AE, Hall SR, Schnepp Z. The evolution of ‘sol–gel’ chemistry as a technique for materials synthesis. Mater Horizons. 2016;3(2):91–112.
   Web of Science ®Google Scholar
• Slowing II, Trewyn BG, Giri S, et al. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater. 2007;17(8):1225–1236.
   Web of Science ®Google Scholar
• Smith GN, Brown P, Rogers SE, et al. Evidence for a critical micelle concentration of surfactants in hydrocarbon solvents. Langmuir. 2013 Mar 12;29(10):3252–3258. PubMed PMID: 23410112.
   PubMed Web of Science ®Google Scholar
• Slowing II, Vivero-Escoto JL, Trewyn BG, et al. Mesoporous silica nanoparticles: structural design and applications. J Mater Chem. 2010;20:37.
   Web of Science ®Google Scholar
• Yu T, KG, McGill LD, et al. Influence of geometry, porosity, And surface characteristics Of silica nanoparticles On acute toxicity: their vasculature effect and tolerance threshold. ACS Nano. 2012;3(2):2289–2301.
   Google Scholar
• Mamaeva V, Sahlgren C, Linden M. Mesoporous silica nanoparticles in medicine–recent advances. Adv Drug Deliv Rev. 2013 May;65(5):689–702. PubMed PMID: 22921598.
   PubMed Web of Science ®Google Scholar
• Wu SH, Mou CY, Lin HP. Synthesis of mesoporous silica nanoparticles. Chem Soc Rev. 2013 May 07;42(9):3862–3875. PubMed PMID: 23403864.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yuan ZF, Wang Y, et al. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J Am Chem Soc. 2013 Apr 03;135(13):5068–5073. PubMed PMID: 23464924.
   PubMed Web of Science ®Google Scholar
• Bouchoucha M, C.-Audreault R, Fortin M-A, et al. Mesoporous silica nanoparticles: selective surface functionalization for optimal relaxometric and drug loading performances. Adv Funct Mater. 2014;24(37):5911–5923.
   Web of Science ®Google Scholar
• Ulrich S, Hirsch C, Diener L, et al. Preparation of ellipsoid-shaped supraparticles with modular compositions and investigation of shape-dependent cell-uptake. RSC Adv. 2016;6(92):89028–89039.
   Web of Science ®Google Scholar
• Watermann A, Brieger J. Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials (Basel). 2017 Jul 22;7(7). PubMed PMID: 28737672; PubMed Central PMCID: PMCPMC5535255. DOI: 10.3390/nano7070189.
   PubMedGoogle Scholar
• Rahmani S, Durand J-O, Charnay C, et al. Synthesis of mesoporous silica nanoparticles and nanorods: application to doxorubicin delivery. Solid State Sciences. 2017;68:25–31.
   Web of Science ®Google Scholar
• He Y, Xu H, Ma S, et al. Fabrication of mesoporous spherical silica nanoparticles and effects of synthesis conditions on particle mesostructure. Mater Lett. 2014;131:361–365.
   Web of Science ®Google Scholar
• Yildirim A, Bayindir M. A porosity difference based selective dissolution strategy to prepare shape-tailored hollow mesoporous silica nanoparticles. J Mater Chem A. 2015;3(7):3839–3846.
   Web of Science ®Google Scholar
• Yang G, Gong H, Qian X, et al. Mesoporous silica nanorods intrinsically doped with photosensitizers as a multifunctional drug carrier for combination therapy of cancer. Nano Res. 2014;8(3):751–764.
   Web of Science ®Google Scholar
• Li Y, Guo W, Su X, et al. Small size mesoporous organosilica nanorods with different aspect ratios: synthesis and cellular uptake. J Colloid Interface Sci. 2018 Feb 15;512:134–140. PubMed PMID: 29055795.
   PubMed Web of Science ®Google Scholar
• Lintang HO, Jalani MA, Yuliati L, et al. Fabrication of mesoporous silica/alumina hybrid membrane film nanocomposites using template sol-gel synthesis of amphiphilic triphenylene. IOP Conf Series: Mater Sci Eng. 2017;202:012003.
   Google Scholar
• Clark Wooten MK, Koganti VR, Zhou S, et al. Synthesis and nanofiltration membrane performance of oriented mesoporous silica thin films on macroporous supports. ACS Appl Mater Interfaces. 2016 Aug 24;8(33):21806–21815. PubMed PMID: 27479791.
   PubMed Web of Science ®Google Scholar
• Ding Y, Fan Y, Zhang Y, et al. Fabrication and optical sensing properties of mesoporous silica nanorod arrays. RSC Adv. 2015;5(110):90659–90666.
   Web of Science ®Google Scholar
• Ren X, Lun Z. Mesoporous silica nanowires synthesized by electrodeposition in AAO. Mater Lett. 2012;68:228–229.
   Web of Science ®Google Scholar
• Gong Z, Ji G, Zheng M, et al. Structural characterization of mesoporous silica nanofibers synthesized within porous alumina membranes. Nanoscale Res Lett. 2009 Jul 14;4(11):1257–1262. PubMed PMID: 20628468; PubMed Central PMCID: PMCPMC2894318.
   PubMed Web of Science ®Google Scholar
• Prem Ananth K, Jose SP, Nathanael AJ, et al. A novel modified sol-gel template synthesis of high aspect ratio silica nanotubes in the presence of phosphoric acid. J Nano Res. 2015;35:27–38.
   Web of Science ®Google Scholar
• Park SB, Joo YH, Kim H, et al. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery. Mater Sci Eng C Mater Biol Appl. 2015 May;50:64–73. PubMed PMID: 25746247.
   PubMed Web of Science ®Google Scholar
• Baodian Yao DF, Morris MA, Lawrence SE. Structural control of mesoporous silica nanowire arrays in porous alumina membrane. Chem Mater. 2004;16:4851–4855.
   Web of Science ®Google Scholar
• Lu Q, FG, Komarneni S, et al. Ordered SBA-15 nanorod arrays inside a porous alumina membrane. J Am Chem Soc. 2004;126:8650–8651.
   PubMed Web of Science ®Google Scholar
• Yang X, He D, He X, et al. Synthesis of hollow mesoporous silica nanorods with controllable aspect ratios for intracellular triggered drug release in cancer cells. ACS Appl Mater Interfaces. 2016 Aug 17;8(32):20558–20569. PubMed PMID: 27411575.
   PubMed Web of Science ®Google Scholar
• Geng H, Chen W, Xu ZP, et al. Shape-controlled hollow mesoporous silica nanoparticles with multifunctional capping for in vitro cancer treatment. Chemistry. 2017 Aug 10;23(45):10878–10885. PubMed PMID: 28580592.
   PubMed Web of Science ®Google Scholar
• Zheng N, Li J, Xu C, et al. Mesoporous silica nanorods for improved oral drug absorption. Artif Cells Nanomed Biotechnol. 2017 Aug 08:1–9. PubMed PMID: 28783976. DOI: 10.1080/21691401.2017.1362414
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang Y, Ran F, et al. A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci Rep. 2017 Jun 23;7(1):4131. PubMed PMID: 28646143; PubMed Central PMCID: PMCPMC5482848.
   PubMedGoogle Scholar
• Yu T, AM, Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano. 2011;5(7):5717–5728.
   PubMed Web of Science ®Google Scholar
• Hao N, Yang H, Li L, et al. The shape effect of mesoporous silica nanoparticles on intracellular reactive oxygen species in A375 cells. New J Chem. 2014;38(9):4258.
   Web of Science ®Google Scholar
• You Y, He L, Ma B, et al. High-drug-loading mesoporous silica nanorods with reduced toxicity for precise cancer therapy against nasopharyngeal carcinoma. Adv Funct Mater. 2017;27:1703313.
   Web of Science ®Google Scholar
• Florek J, Caillard R, Kleitz F. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers. Nanoscale. 2017 Oct 19;9(40):15252–15277. PubMed PMID: 28984885. .
   PubMed Web of Science ®Google Scholar
• Doadrio AL, Sanchez-Montero JM, Doadrio JC, et al. Mesoporous silica nanoparticles as a new carrier methodology in the controlled release of the active components in a polypill. Eur J Pharm Sci. 2017 Jan 15;97:1–8. PubMed PMID: 27818251.
   PubMed Web of Science ®Google Scholar
• Lu N, Fan W, Yi X, et al. Biodegradable hollow mesoporous organosilica nanotheranostics for mild hyperthermia-induced bubble-enhanced oxygen-sensitized radiotherapy. ACS Nano. 2018 Feb 5. PubMed PMID: 29384652. DOI:10.1021/acsnano.7b08103.
   Web of Science ®Google Scholar
• Hu JJ, Xiao D, Zhang XZ. Advances in peptide functionalization on mesoporous silica nanoparticles for controlled drug release. Small. 2016 Jul;12(25):3344–3359. PubMed PMID: 27152737.
   PubMed Web of Science ®Google Scholar
• Yang Y, Jambhrunkar M, Abbaraju PL, et al. Understanding the effect of surface chemistry of mesoporous silica nanorods on their vaccine adjuvant potency. Adv Healthc Mater. 2017 Sep;6(17):1700466. PubMed PMID: 28557331.
   Web of Science ®Google Scholar
• Wu Y, Tang W, Wang P, et al. Cytotoxicity and cellular uptake of amorphous silica nanoparticles in human cancer cells. Part Part Syst Characterization. 2015;32(7):779–787.
   Web of Science ®Google Scholar
• Möller K, Bein T. Talented mesoporous silica nanoparticles. Chem Mater. 2017;29(1):371–388.
   Web of Science ®Google Scholar
• Kwon D, Cha BG, Cho Y, et al. Extra-large pore mesoporous silica nanoparticles for directing in vivo M2 macrophage polarization by delivering IL-4. Nano Lett. 2017 May 10;17(5):2747–2756. PubMed PMID: 28422506.
   PubMed Web of Science ®Google Scholar
• Croissant J, Cattoen X, Man MW, et al. Biodegradable ethylene-bis(propyl)disulfide-based periodic mesoporous organosilica nanorods and nanospheres for efficient in-vitro drug delivery. Adv Mater. 2014 Sep 17;26(35):6174–6180. PubMed PMID: 25042639.
   PubMed Web of Science ®Google Scholar
• Hu Q, Li H, Wang L, et al. DNA nanotechnology-enabled drug delivery systems. Chem Rev. 2018 Feb 21. PubMed PMID: 29465222. DOI:10.1021/acs.chemrev.7b00663.
   Google Scholar
• Zhang P, Cheng F, Zhou R, et al. DNA-hybrid-gated multifunctional mesoporous silica nanocarriers for dual-targeted and microRNA-responsive controlled drug delivery. Angew Chem Int Ed Engl. 2014 Feb 24;53(9):2371–2375. PubMed PMID: 24470397.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Quan G, Wu Q, et al. Mesoporous silica nanoparticles for drug and gene delivery. Acta Pharmaceutica Sinica B. 2018;8(2):165–177.
   PubMed Web of Science ®Google Scholar
• Chen L, She X, Wang T, et al. Mesoporous silica nanorods toward efficient loading and intracellular delivery of siRNA. J Nanoparticle Res. 2018;20(2). DOI:10.1007/s11051-017-4115-0
   Web of Science ®Google Scholar
• Kinnear C, Moore TL, Rodriguez-Lorenzo L, et al. Form follows function: nanoparticle shape and its implications for nanomedicine. Chem Rev. 2017 Sep 13;117(17):11476–11521. PubMed PMID: 28862437.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu Z, Liu J, et al. Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors. Expert Opin Drug Deliv. 2018 Apr;15(4):379–395. PubMed PMID: 29264946.
   PubMed Web of Science ®Google Scholar
• Shao D, Lu MM, Zhao YW, et al. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution. Acta Biomater. 2017 Feb;49:531–540. PubMed PMID: 27836804.
   PubMed Web of Science ®Google Scholar
• Pelras T, Duong HTT, Kim BJ, et al. A ‘grafting from’ approach to polymer nanorods for pH-triggered intracellular drug delivery. Polymer. 2017;112:244–251.
   Web of Science ®Google Scholar
• Meng H, SY, Li Z, et al. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano. 2011;5(6):4434–4447.
   PubMed Web of Science ®Google Scholar
• von Roemeling C, Jiang W, Chan CK, et al. Breaking down the barriers to precision cancer nanomedicine. Trends Biotechnol. 2017 Feb;35(2):159–171. PubMed PMID: 27492049.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang J, Yang Y, et al. Rotation-facilitated rapid transport of nanorods in mucosal tissues. Nano Lett. 2016 Nov 09;16(11):7176–7182. PubMed PMID: 27700115.
   PubMed Web of Science ®Google Scholar
• Huang X, LL, Liu T, et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano. 2011;5(7):5390–5399.
   PubMed Web of Science ®Google Scholar
• Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2007 Apr;2(4):249–255. PubMed PMID: 18654271; PubMed Central PMCID: PMCPMC2740330.
   PubMed Web of Science ®Google Scholar
• von Maltzahn G, Park JH, Agrawal A, et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 2009 May 1;69(9):3892–3900. PubMed PMID: 19366797; PubMed Central PMCID: PMCPMC2712876.
   PubMed Web of Science ®Google Scholar
• Bourquin J, Milosevic A, Hauser D, et al. Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials. Adv Mater. 2018 Feb 1;30:1704307. PubMed PMID: 29389049.
   PubMed Web of Science ®Google Scholar
• Yang G, Sun X, Liu J, et al. Light-responsive, singlet-oxygen-triggered on-demand drug release from photosensitizer-doped mesoporous silica nanorods for cancer combination therapy. Adv Funct Mater. 2016;26(26):4722–4732.
   Web of Science ®Google Scholar
• Li D, Tang Z, Gao Y, et al. A bio-inspired rod-shaped nanoplatform for strongly infecting tumor cells and enhancing the delivery efficiency of anticancer drugs. Adv Funct Mater. 2016;26(1):66–79.
   Web of Science ®Google Scholar
• Zhou Z, Ma X, Jin E, et al. Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery. Biomaterials. 2013 Jul;34(22):5722–5735. PubMed PMID: 23639529.
   PubMed Web of Science ®Google Scholar
• Akiyama Y, Mori T, Katayama Y, et al. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release. 2009 Oct 1;139(1):81–84. PubMed PMID: 19538994.
   PubMed Web of Science ®Google Scholar
• Li L, Liu T, Fu C, et al. Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape. Nanomedicine. 2015 Nov;11(8):1915–1924. PubMed PMID: 26238077.
   PubMed Web of Science ®Google Scholar
• Hu KW, Hsu KC, Yeh CS. pH-dependent biodegradable silica nanotubes derived from Gd(OH)3 nanorods and their potential for oral drug delivery and MR imaging. Biomaterials. 2010 Sep;31(26):6843–6848. PubMed PMID: 20542331. .
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu H. Core-shell-type magnetic mesoporous silica nanocomposites for bioimaging and therapeutic agent delivery. Adv Mater. 2015 Jan 21;27(3):576–585. PubMed PMID: 25238634. .
   PubMed Web of Science ®Google Scholar
• Chen YS, Frey W, Kim S, et al. Silica-coated gold nanorods as photoacoustic signal nanoamplifiers. Nano Lett. 2011 Feb 09;11(2):348–354. PubMed PMID: 21244082; PubMed Central PMCID: PMCPMC3040682.
   PubMed Web of Science ®Google Scholar
• Peng H, Dong R, Wang S, et al. A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside. Int J Pharm. 2013 Mar 25;446(1–2):153–159. PubMed PMID: 23395877.
   PubMed Web of Science ®Google Scholar
• Obare SO, NRJ, Murphy CJ. Preparation of polystyrene- and silica-coated gold nanorods and their use as templates for the synthesis of hollow nanotubes. Nano Lett. 2001;1(11):601–603.
   Web of Science ®Google Scholar
• Dujardin E, Blaseby M, Mann S. Synthesis of mesoporous silica by sol–gel mineralisation of cellulose nanorod nematic suspensions. J Mater Chem. 2003;13(4):696–699.
   Web of Science ®Google Scholar
• Pang X, Tang F. Morphological control of mesoporous materials using inexpensive silica sources. Micropor Mesopor Mat. 2005;85(1–2):1–6.
   Web of Science ®Google Scholar
• Altintoprak K, Seidenstucker A, Welle A, et al. Peptide-equipped tobacco mosaic virus templates for selective and controllable biomineral deposition. Beilstein J Nanotechnol. 2015;6:1399–1412. PubMed PMID: 26199844; PubMed Central PMCID: PMCPMC4505087.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, AJT, Dai Q, et al. Analysis of nanoparticle delivery to tumours. Nat Rev. 2016;1(1):1–12.
   Google Scholar
• Pan L, Liu J, He Q, et al. MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression. Adv Mater. 2014 Oct 22;26(39):6742–6748. PubMed PMID: 25159109.
   PubMed Web of Science ®Google Scholar
• Li ZY, Liu Y, Hu JJ, et al. Stepwise-acid-active multifunctional mesoporous silica nanoparticles for tumor-specific nucleus-targeted drug delivery. ACS Appl Mater Interfaces. 2014 Aug 27;6(16):14568–14575. PubMed PMID: 25103086.
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang YS, Pang B, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014 Nov 10;53(46):12320–12364. PubMed PMID: 25294565.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang X, Li P-Z, et al. Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer-targeted drug delivery in vivo. Adv Funct Mater. 2014;24(17):2450–2461.
   Web of Science ®Google Scholar
• Min Y, Caster JM, Eblan MJ, et al. Clinical translation of nanomedicine. Chem Rev. 2015 Oct 14;115(19):11147–11190. PubMed PMID: 26088284; PubMed Central PMCID: PMCPMC4607605.
   PubMed Web of Science ®Google Scholar
• Shi Y, Miller ML, Di Pasqua AJ. Biocompatibility of mesoporous silica nanoparticles? Comments Inorg Chem. 2015;36(2):61–80.
   Web of Science ®Google Scholar
• Kloust H, Zierold R, Merkl J-P, et al. Synthesis of iron oxide nanorods using a template mediated approach. Chem Mater. 2015;27(14):4914–4917.
   Web of Science ®Google Scholar
• Si J-C, Xing Y, Peng M-L, et al. Solvothermal synthesis of tunable iron oxide nanorods and their transfer from organic phase to water phase. CrystEngComm. 2014;16(4):512–516.
   Web of Science ®Google Scholar
• Croissant JG, Fatieiev Y, Almalik A, et al. Mesoporous silica and organosilica nanoparticles: physical chemistry, biosafety, delivery strategies, and biomedical applications. Adv Healthc Mater. 2018 Feb;7(4). PubMed PMID: 29193848. DOI:10.1002/adhm.201700831.
   Web of Science ®Google Scholar
• Paris JL, Colilla M, Izquierdo-Barba I, et al. Tuning mesoporous silica dissolution in physiological environments: a review. J Mater Sci. 2017;52(15):8761–8771.
   Web of Science ®Google Scholar
• Omar H, Croissant JG, Alamoudi K, et al. Biodegradable magnetic silica@iron oxide nanovectors with ultra-large mesopores for high protein loading, magnetothermal release, and delivery. J Control Release. 2017 Aug 10;259:187–194. PubMed PMID: 27913308.
   PubMed Web of Science ®Google Scholar
• Maggini L, Cabrera I, Ruiz-Carretero A, et al. Breakable mesoporous silica nanoparticles for targeted drug delivery. Nanoscale. 2016 Apr 07;8(13):7240–7247. PubMed PMID: 26974603.
   PubMed Web of Science ®Google Scholar